EDP-323

DRUG3 trials

Sponsors

Enanta Pharmaceuticals, Inc

Conditions

Drug Drug InteractionDrug Drug Interaction (DDI)RSV Infection

Phase 1

A Study of EDP-323 in Healthy Subjects

CompletedNCT05587478

Enanta Pharmaceuticals, IncRSV Infection

Start: 2022-09-29End: 2023-03-29Updated: 2023-09-01

A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

CompletedNCT06847464

Enanta Pharmaceuticals, IncDrug Drug Interaction (DDI), RSV Infection

Start: 2025-01-27End: 2025-06-01Updated: 2025-07-01

A Study to Evaluate the Drug-Drug Interaction of EDP-323 With Midazolam, Caffeine, and Rosuvastatin in Healthy Participants

CompletedNCT06917508

Enanta Pharmaceuticals, IncDrug Drug Interaction, RSV Infection

Start: 2025-03-13End: 2025-06-13Updated: 2025-07-01